Parasitology is the scientific study of parasites, organisms that live in or on another organism (host) and derive nutrients at the host's expense. It encompasses a broad range of organisms, including protozoa, helminths (worms), and arthropods, each with distinct life cycles and adaptations to parasitic lifestyles. Parasitologists investigate the morphology, physiology, ecology, and evolution of parasites, aiming to understand their biology and the interactions with their hosts. This field is vital for elucidating the complex dynamics of parasitic infections and developing strategies for control and prevention. Research in parasitology contributes to advancements in diagnostics, treatments, and vaccines for parasitic diseases that impact human health, agriculture, and ecosystems. Notable examples include malaria, schistosomiasis, and various veterinary parasitoses. Technological advances, such as molecular tools and imaging techniques, have revolutionized parasitology, allowing for more accurate identification of parasites and deeper insights into their biology. Parasitologists collaborate across disciplines to address the global challenges posed by parasitic infections and contribute to the improvement of public health and agricultural practices.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States